UNH vs CRL
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Charles River Laboratories International, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | CRL |
|---|---|---|
| Price | $407.46 | $337.97 |
| Market cap | $365.09B | $16.19B |
| P/E ratio | 23.3 | 367.4 |
| ROE | 15.77% | 1.27% |
| Profit margin | 3.53% | 1.01% |
| Revenue growth | -0.40% | -2.20% |
| Dividend yield | 2.28% | 0.00% |
| Beta | 0.52 | 1.34 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs CRL in plain English
- UNH is the bigger company — about 22.5× the market cap of CRL.
- UNH is cheaper on earnings (P/E 23.3 vs 367.4).
- UNH earns a higher return on equity (16% vs 1%).
- UNH is growing revenue faster (-0% vs -2%).
- UNH pays a dividend (2.28%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
CRL return calculator
See what $1,000 in Charles River Laboratories International, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.